Literature DB >> 7040244

Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.

A Fox, R R Brown, S K Anderle, C Chetty, W J Cromartie, H Gooder, J H Schwab.   

Abstract

The covalently bound polymers of peptidoglycan and group-specific polysaccharide (PG-APS) were isolated from the cell walls of group A streptococci. Arthritis was induced in rats with a single intraperitoneal injection of an aqueous suspension of PG-APS fragments derived by sonication. The joint lesions induced with this polydisperse suspension followed a bimodal pattern consisting of an acute phase, which reached a peak 5 days after injection and then receded, followed by a chronic, remittent, erosive arthritis lasting several months. The relative severities of the acute and chronic phases could be manipulated by selection of the size of PG-APS fragments. The fragments of PG-APS obtained by sonic treatment were resolved on the basis of size into three major populations by sucrose gradient or differential centrifugation. Based upon light scattering and gel filtration, the average molecular weight of the largest family of fragments was estimated to be about 500 x 10(6), the intermediate fragments were 50 x 10(6) daltons, and the predominant size in the smallest population was 5.3 x 10(6) daltons. The larger fragments induced negligible acute inflammation, but chronic disease became apparent 5 to 9 weeks after injection. The smallest fragments induced the most severe acute inflammation, with relatively little late, chronic joint disease. The particles of intermediate size induced moderate acute inflammation and the most severe chronic, erosive joint lesions. A single injection of fragments of the isolated peptidoglycan moiety of the PG-APS induced only a moderate acute inflammation of joints, with no apparent capacity to maintain the injury and induce chronic disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040244      PMCID: PMC351147          DOI: 10.1128/iai.35.3.1003-1010.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls.

Authors:  R L Clark; J T Cuttino; S K Anderle; W J Cromartie; J H Schwab
Journal:  Arthritis Rheum       Date:  1979-01

2.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  A modification of the Park and Johnson reducing sugar determination suitable for the assay of insoluble materials: its application to bacterial cell walls.

Authors:  J S Thompson; G D Shockman
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

4.  Biological properties of streptococcal cell-wall particles. 3. Dermonecrotic reaction to cell-wall mucopeptides.

Authors:  E M Abdulla; J H Schwab
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

5.  Degradation of streptococcal cell wall antigens in vivo.

Authors:  J H Schwab; S H Ohanian
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

6.  Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry.

Authors:  A Fox; J H Schwab; T Cochran
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Relation of particle size of C polysaccharide complexes of group A streptococci to toxic effects on connective tissue.

Authors:  B S ROBERSON; J H SCHWAB; W J CROMARTIE
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

8.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

9.  Persistence of group a streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue.

Authors:  S H Ohanian; J H Schwab
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  64 in total

1.  Influence of decontamination on induction of arthritis in Lewis rats by cell wall fragments of Eubacterium aerofaciens. Arthropathic properties of indigenous anaerobic bacteria.

Authors:  J Kool; A J Severijnen; I S Klasen; M Y Gerrits-Boeye; M P Hazenberg
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

2.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation.

Authors:  Sukumar Saha; Jin Qi; Shiyong Wang; Minhui Wang; Xinna Li; Yun-Gi Kim; Gabriel Núñez; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

3.  Opsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptors.

Authors:  K B Pryzwansky; J D Lambris; E K MacRae; J H Schwab
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis.

Authors:  S K Anderle; J B Allen; R L Wilder; R A Eisenberg; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

6.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

Authors:  S A Stimpson; R A Lerch; D R Cleland; D P Yarnall; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

8.  Eicosanoid regulation of acute intestinal vascular permeability induced by intravenous peptidoglycan-polysaccharide polymers.

Authors:  C J Woolverton; J J White; R B Sartor
Journal:  Agents Actions       Date:  1989-03

9.  Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: implications for pathogenesis of chronic inflammation.

Authors:  P A Leong; J H Schwab; M S Cohen
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Bacterial cell wall polymers (peptidoglycan-polysaccharide) cause reactivation of arthritis.

Authors:  S N Lichtman; S Bachmann; S R Munoz; J H Schwab; D E Bender; R B Sartor; J J Lemasters
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.